Literature DB >> 8464036

Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction.

Y Yamamoto1, K Kamiya, S Terao.   

Abstract

In order to elucidate the mode of the thromboxane A2 (TXA2) receptor-ligand interaction at the molecular level, a model for the human TXA2 receptor, a member of the G protein-coupled receptor family with seven transmembrane segments, was constructed on the basis of its amino acid sequence, which was determined recently (Hirata, M.; et al. Nature 1991, 349, 617-620). First, we made a model for the human beta 2-adrenergic receptor using its amino acid sequence and the known helix arrangement of bacteriorhodopsin. Then, a TXA2 receptor model was constructed based on the beta 2 receptor model and was used to analyze the receptor-ligand interaction. The ligand-binding pocket of the TXA2 receptor includes a serine residue from segment V, an arginine residue from segment VII, and a large hydrophobic pocket between these two residues. These results are consistent with the known properties of TXA2 and TXA2 antagonists having a hydrogen-bonding group such as hydroxyl, a carboxyl group, and a hydrophobic moiety. This model should be helpful for rational design of potent TXA2 antagonists.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464036     DOI: 10.1021/jm00059a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor.

Authors:  Feng Ni; Shui-Ping So; Vanessa Cervantes; Ke-He Ruan
Journal:  FEBS J       Date:  2007-11-27       Impact factor: 5.542

3.  Lead compound design for TPR/COX dual inhibition.

Authors:  Abhay Krishna; Arpita Yadav
Journal:  J Mol Model       Date:  2012-05-16       Impact factor: 1.810

4.  BUNDLE: a program for building the transmembrane domains of G-protein-coupled receptors.

Authors:  M Filizola; J J Perez; M Cartenì-Farina
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

5.  Potent, long-acting cyclopentane-1,3-Dione thromboxane (A2)-receptor antagonists.

Authors:  Xiaozhao Wang; Li Liu; Longchuan Huang; Katie Herbst-Robinson; Anne-Sophie Cornec; Michael J James; Shimpei Sugiyama; Marcella Bassetto; Andrea Brancale; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith; Kurt R Brunden; Carlo Ballatore
Journal:  ACS Med Chem Lett       Date:  2014-07-24       Impact factor: 4.345

6.  Cyclopentane-1,3-dione: a novel isostere for the carboxylic acid functional group. Application to the design of potent thromboxane (A2) receptor antagonists.

Authors:  Carlo Ballatore; James H Soper; Francesco Piscitelli; Michael James; Longchuan Huang; Onur Atasoylu; Donna M Huryn; John Q Trojanowski; Virginia M-Y Lee; Kurt R Brunden; Amos B Smith
Journal:  J Med Chem       Date:  2011-09-09       Impact factor: 7.446

7.  Automated method for modeling seven-helix transmembrane receptors from experimental data.

Authors:  P Herzyk; R E Hubbard
Journal:  Biophys J       Date:  1995-12       Impact factor: 4.033

8.  Functional interaction of the carboxylic acid group of agonists and the arginine residue of the seventh transmembrane domain of prostaglandin E receptor EP3 subtype.

Authors:  C Chang; M Negishi; N Nishigaki; A Ichikawa
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

9.  Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells.

Authors:  C Huang; H H Tai
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

10.  Modelling the structures of G protein-coupled receptors aided by three-dimensional validation.

Authors:  Siavoush Dastmalchi; W Bret Church; Michael B Morris
Journal:  BMC Bioinformatics       Date:  2008       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.